TELMISARTAN

TELMISARTAN was reported 18261 times

TELMISARTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROLOGIC NEGLECT SYNDROME 182 0.3273
1 URETHRAL CARUNCLE 17 0.2537
2 AMAUROSIS FUGAX 240 0.2228
3 CAROTID ARTERY THROMBOSIS 188 0.2214
4 PULMONARY VALVE DISEASE 25 0.1923
5 INFUSION SITE STREAKING 15 0.1724
6 GASTRIC PH INCREASED 19 0.1652
7 ADJUSTMENT DISORDER 181 0.1392
8 HEPATOJUGULAR REFLUX 22 0.1325
9 ELECTROCARDIOGRAM Q WAVE ABNORMAL 24 0.1026
10 CARCINOID TUMOUR PULMONARY 21 0.0871
11 GRANULOMA SKIN 70 0.0853
12 LABILE HYPERTENSION 20 0.0725
13 PERSONALITY DISORDER 184 0.0702
14 DRUG SPECIFIC ANTIBODY 83 0.0606
15 PHYSICAL EXAMINATION ABNORMAL 22 0.0574
16 URINARY TRACT DISORDER 233 0.0517
17 BLOOD PARATHYROID HORMONE DECREASED 74 0.0499
18 INSULIN-LIKE GROWTH FACTOR DECREASED 25 0.0473
19 CAROTID ARTERIOSCLEROSIS 48 0.0465
20 OCCULT BLOOD 22 0.0419
21 EPIDERMAL NECROSIS 38 0.0390
22 APPENDICOLITH 15 0.0388
23 HAEMORRHAGIC STROKE 289 0.0370
24 GANGRENE 201 0.0333
25 CREATININE RENAL CLEARANCE INCREASED 24 0.0321
26 BRASH SYNDROME 44 0.0313
27 PANNICULITIS 74 0.0306
28 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 18 0.0269
29 BLOOD PRESSURE DIASTOLIC ABNORMAL 68 0.0267
30 RHEUMATOID NODULE 73 0.0265
31 BITE 19 0.0263
32 ARTERIAL OCCLUSIVE DISEASE 201 0.0255
33 DRUG TOLERANCE DECREASED 71 0.0253
34 SENSORY LOSS 203 0.0252
35 HEMIPLEGIA 207 0.0249
36 REDUCED FACIAL EXPRESSION 25 0.0246
37 BLOOD PRESSURE SYSTOLIC ABNORMAL 58 0.0234
38 ATROPHIC VULVOVAGINITIS 17 0.0233
39 AFFECT LABILITY 220 0.0228
40 OCULAR DISCOMFORT 244 0.0217
41 SMALL FIBRE NEUROPATHY 16 0.0217
42 ENDOMETRIOSIS 103 0.0216
43 LUPUS VULGARIS 27 0.0214
44 GOUTY ARTHRITIS 17 0.0213
45 SYSTOLIC DYSFUNCTION 22 0.0209
46 PRODUCT MONITORING ERROR 30 0.0208
47 LIGHT CHAIN ANALYSIS INCREASED 21 0.0203
48 MULTIPLE DRUG THERAPY 15 0.0199
49 SINUS ARREST 31 0.0198
50 DIZZINESS EXERTIONAL 15 0.0197
51 BREATH SOUNDS ABNORMAL 97 0.0197
52 HELICOBACTER GASTRITIS 24 0.0194
53 GIANT CELL ARTERITIS 16 0.0193
54 GENERALISED OEDEMA 234 0.0189
55 HEAD DISCOMFORT 321 0.0181
56 MOTOR DYSFUNCTION 182 0.0178
57 SINUS CONGESTION 237 0.0175
58 PULMONARY FUNCTION TEST ABNORMAL 27 0.0173
59 ECHOCARDIOGRAM ABNORMAL 24 0.0171
60 RHEUMATOID FACTOR POSITIVE 99 0.0171
61 ALTERED STATE OF CONSCIOUSNESS 361 0.0166
62 RETINITIS 28 0.0162
63 SKIN NECROSIS 80 0.0154
64 MUSCLE SPASTICITY 183 0.0149
65 GASTROINTESTINAL BACTERIAL INFECTION 17 0.0149
66 CARDIAC DISCOMFORT 29 0.0144
67 PRODUCT USED FOR UNKNOWN INDICATION 18 0.0143
68 APRAXIA 21 0.0142
69 SUBCLAVIAN VEIN THROMBOSIS 16 0.0140
70 RED BLOOD CELL SEDIMENTATION RATE INCREASED 152 0.0137
71 COORDINATION ABNORMAL 191 0.0137
72 DIASTOLIC DYSFUNCTION 42 0.0136
73 MITRAL VALVE DISEASE 24 0.0135
74 BRADYARRHYTHMIA 22 0.0134
75 SKIN HAEMORRHAGE 198 0.0133
76 STENOSIS 25 0.0133
77 RESPIRATORY TRACT CONGESTION 211 0.0133
78 DYSPNOEA AT REST 38 0.0131
79 SINUS NODE DYSFUNCTION 24 0.0131
80 BLOOD PHOSPHORUS INCREASED 35 0.0128
81 LISTLESS 42 0.0127
82 BLOOD PRESSURE SYSTOLIC INCREASED 241 0.0123
83 HEMIPARESIS 208 0.0123
84 BLOOD PRESSURE DIASTOLIC DECREASED 85 0.0115
85 HAEMATEMESIS 286 0.0113
86 RALES 65 0.0112
87 SINUS DISORDER 214 0.0108
88 ANAEMIA MACROCYTIC 23 0.0108
89 RENAL FUNCTION TEST ABNORMAL 50 0.0108
90 LEFT VENTRICULAR HYPERTROPHY 46 0.0107
91 JOINT NOISE 21 0.0107
92 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 19 0.0107
93 BUNDLE BRANCH BLOCK LEFT 44 0.0104
94 VASOPLEGIA SYNDROME 17 0.0104
95 HYPERCALCAEMIA 126 0.0102
96 SEDATION COMPLICATION 26 0.0102
97 ASCITES 297 0.0101
98 ACTINIC KERATOSIS 26 0.0100
99 SNEEZING 224 0.0100
100 PHOTOPHOBIA 185 0.0098
101 PRESYNCOPE 239 0.0098
102 MYELITIS 15 0.0097
103 EATING DISORDER 206 0.0097
104 VENTRICULAR HYPOKINESIA 31 0.0096
105 BLOOD PARATHYROID HORMONE INCREASED 28 0.0096
106 VENTRICULAR ARRHYTHMIA 35 0.0096
107 CARDIAC FAILURE CHRONIC 40 0.0094
108 VITAMIN B12 DECREASED 27 0.0094
109 OLIGURIA 58 0.0093
110 HYPOVENTILATION 30 0.0092
111 PULSE ABNORMAL 22 0.0091
112 RADICULOPATHY 24 0.0091
113 MENOPAUSAL SYMPTOMS 21 0.0090
114 TOXIC EPIDERMAL NECROLYSIS 136 0.0089
115 BLOOD CHLORIDE DECREASED 23 0.0089
116 HYPERPHOSPHATAEMIA 19 0.0088
117 COMPARTMENT SYNDROME 23 0.0088
118 HAEMATURIA 301 0.0088
119 HYPERPARATHYROIDISM SECONDARY 22 0.0088
120 SYNOVITIS 155 0.0086
121 DIPLOPIA 222 0.0085
122 RHEUMATIC FEVER 38 0.0085
123 CYSTITIS 266 0.0083
124 ANGINA PECTORIS 237 0.0083
125 DIFFUSE ALOPECIA 15 0.0081
126 ATRIOVENTRICULAR BLOCK COMPLETE 54 0.0081
127 CREATININE RENAL CLEARANCE DECREASED 32 0.0080
128 BLOOD PRESSURE INADEQUATELY CONTROLLED 48 0.0080
129 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 69 0.0078
130 BLOOD SODIUM INCREASED 21 0.0078
131 CARCINOEMBRYONIC ANTIGEN INCREASED 15 0.0077
132 CAROTID ARTERY STENOSIS 27 0.0077
133 HYPONATRAEMIA 428 0.0076
134 APHASIA 228 0.0075
135 SPINAL STENOSIS 31 0.0075
136 DISTRIBUTIVE SHOCK 17 0.0075
137 STARING 18 0.0074
138 BLOOD IMMUNOGLOBULIN E INCREASED 18 0.0074
139 RENAL TUBULAR ACIDOSIS 16 0.0073
140 BLINDNESS 291 0.0071
141 STAPHYLOCOCCUS TEST POSITIVE 15 0.0071
142 LACTIC ACIDOSIS 230 0.0071
143 OPTIC NEUROPATHY 15 0.0071
144 CHRONIC GASTRITIS 16 0.0071
145 CARDIO-RESPIRATORY ARREST 296 0.0071
146 AORTIC VALVE INCOMPETENCE 30 0.0070
147 ABSCESS INTESTINAL 15 0.0070
148 BASAL CELL CARCINOMA 108 0.0069
149 ARTHRITIS 542 0.0069
150 HYPERSENSITIVITY VASCULITIS 18 0.0068
151 HYPOMAGNESAEMIA 95 0.0068
152 DIABETIC NEPHROPATHY 15 0.0068
153 BONE EROSION 24 0.0068
154 DRUG ERUPTION 120 0.0068
155 BLOOD PRESSURE INCREASED 1025 0.0067
156 HYPERTENSIVE CRISIS 74 0.0066
157 PEMPHIGOID 50 0.0066
158 SWOLLEN JOINT COUNT INCREASED 21 0.0066
159 ENTERITIS 42 0.0066
160 EUGLYCAEMIC DIABETIC KETOACIDOSIS 27 0.0065
161 BRONCHIOLITIS 23 0.0065
162 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 67 0.0065
163 LUNG OPACITY 17 0.0064
164 LEFT VENTRICULAR DYSFUNCTION 43 0.0064
165 CONTRAINDICATED PRODUCT ADMINISTERED 193 0.0064
166 ULCER 101 0.0063
167 MONOCYTE COUNT INCREASED 23 0.0063
168 TINNITUS 290 0.0063
169 BRADYPNOEA 17 0.0063
170 DYSARTHRIA 237 0.0063
171 HEART VALVE INCOMPETENCE 18 0.0063
172 EXERCISE TOLERANCE DECREASED 36 0.0062
173 BLOOD URIC ACID INCREASED 36 0.0062
174 HYPERKALAEMIA 215 0.0061
175 SPUTUM DISCOLOURED 58 0.0061
176 BLOOD PRESSURE FLUCTUATION 146 0.0061
177 PULMONARY FIBROSIS 116 0.0060
178 COMA 287 0.0060
179 LUNG ADENOCARCINOMA 18 0.0060
180 BILE DUCT STONE 19 0.0060
181 CORONARY ARTERY STENOSIS 30 0.0060
182 C-REACTIVE PROTEIN INCREASED 216 0.0059
183 CHRONIC SINUSITIS 22 0.0059
184 NEPHROGENIC ANAEMIA 27 0.0058
185 BENIGN PROSTATIC HYPERPLASIA 30 0.0058
186 EYE PAIN 323 0.0057
187 MITRAL VALVE INCOMPETENCE 64 0.0056
188 FORCED EXPIRATORY VOLUME DECREASED 16 0.0056
189 FAECES SOFT 41 0.0056
190 PROTEIN URINE PRESENT 28 0.0056
191 HYPERLACTACIDAEMIA 15 0.0056
192 KERATITIS 17 0.0056
193 IRON DEFICIENCY 25 0.0056
194 AZOTAEMIA 22 0.0055
195 CLUMSINESS 15 0.0055
196 HYPERCHOLESTEROLAEMIA 53 0.0055
197 TRICUSPID VALVE INCOMPETENCE 43 0.0054
198 OLIGOHYDRAMNIOS 18 0.0054
199 BLOOD PRESSURE ABNORMAL 107 0.0054
200 CARDIOMEGALY 66 0.0054
201 POLYMYALGIA RHEUMATICA 17 0.0053
202 METABOLIC ENCEPHALOPATHY 16 0.0053
203 SUPRAVENTRICULAR EXTRASYSTOLES 18 0.0053
204 WHITE BLOOD CELL COUNT ABNORMAL 34 0.0053
205 MYASTHENIA GRAVIS 43 0.0053
206 BODY TEMPERATURE DECREASED 52 0.0053
207 IMMOBILE 23 0.0053
208 INTERNATIONAL NORMALISED RATIO ABNORMAL 18 0.0052
209 DRUG SPECIFIC ANTIBODY PRESENT 34 0.0052
210 ANGIOPATHY 29 0.0052
211 TROPONIN INCREASED 39 0.0051
212 NAIL DISCOLOURATION 20 0.0051
213 CATARACT 300 0.0050
214 POLYNEUROPATHY 60 0.0050
215 SUBCUTANEOUS ABSCESS 24 0.0050
216 SLEEP APNOEA SYNDROME 95 0.0050
217 VITAMIN B12 DEFICIENCY 20 0.0049
218 DECREASED INTEREST 29 0.0049
219 GLOMERULAR FILTRATION RATE DECREASED 60 0.0049
220 ORTHOSTATIC HYPOTENSION 85 0.0049
221 ARTERIOSCLEROSIS CORONARY ARTERY 32 0.0048
222 PRESCRIBED UNDERDOSE 96 0.0048
223 HYPOKALAEMIA 220 0.0048
224 BREAST CANCER RECURRENT 15 0.0047
225 GOUT 85 0.0047
226 CEREBRAL DISORDER 35 0.0047
227 RHINITIS 38 0.0047
228 SKIN ULCER 121 0.0047
229 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 80 0.0047
230 LIVER ABSCESS 15 0.0046
231 HEPATIC STEATOSIS 86 0.0046
232 ACUTE KIDNEY INJURY 705 0.0046
233 DUODENAL ULCER PERFORATION 34 0.0046
234 TOXIC ENCEPHALOPATHY 23 0.0045
235 DRUG-INDUCED LIVER INJURY 142 0.0045
236 BRADYCARDIA 240 0.0045
237 CARDIAC FAILURE ACUTE 30 0.0045
238 UPPER-AIRWAY COUGH SYNDROME 37 0.0045
239 CEREBRAL HAEMATOMA 15 0.0045
240 SYNCOPE 446 0.0045
241 HYPERLIPIDAEMIA 53 0.0044
242 HYPOVOLAEMIC SHOCK 21 0.0044
243 HYPERTENSION 928 0.0044
244 HYPERURICAEMIA 18 0.0044
245 BLOOD UREA INCREASED 73 0.0044
246 RHINORRHOEA 281 0.0043
247 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 31 0.0043
248 GLAUCOMA 83 0.0043
249 AORTIC STENOSIS 15 0.0043
250 TACHYCARDIA 381 0.0043
251 NOCTURIA 52 0.0043
252 HELICOBACTER INFECTION 44 0.0043
253 FULL BLOOD COUNT ABNORMAL 45 0.0043
254 FOREIGN BODY 17 0.0042
255 EJECTION FRACTION DECREASED 66 0.0042
256 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 26 0.0042
257 ACUTE MYOCARDIAL INFARCTION 124 0.0042
258 METASTATIC NEOPLASM 18 0.0042
259 TUBULOINTERSTITIAL NEPHRITIS 78 0.0042
260 HYPOGLYCAEMIA 200 0.0041
261 HYPOCALCAEMIA 78 0.0041
262 DRUG INTOLERANCE 398 0.0041
263 BLOOD PRESSURE DIASTOLIC INCREASED 19 0.0041
264 DRUG INTERACTION 648 0.0041
265 OXYGEN SATURATION DECREASED 229 0.0041
266 SUPRAVENTRICULAR TACHYCARDIA 39 0.0041
267 PROSTATOMEGALY 16 0.0041
268 UMBILICAL HERNIA 19 0.0041
269 OSTEOARTHRITIS 172 0.0041
270 CONCOMITANT DISEASE AGGRAVATED 25 0.0040
271 DRUG LEVEL INCREASED 67 0.0040
272 IDIOPATHIC PULMONARY FIBROSIS 16 0.0040
273 BLOOD IRON DECREASED 48 0.0040
274 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 193 0.0040
275 RHEUMATOID ARTHRITIS 456 0.0040
276 NEPHROPATHY TOXIC 45 0.0040
277 MUSCULOSKELETAL DISCOMFORT 69 0.0040
278 DELIRIUM 139 0.0040
279 CHRONIC KIDNEY DISEASE 303 0.0040
280 PELVIC FRACTURE 31 0.0040
281 SQUAMOUS CELL CARCINOMA OF SKIN 24 0.0040
282 NON-SMALL CELL LUNG CANCER 19 0.0040
283 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 20 0.0039
284 HAEMODYNAMIC INSTABILITY 30 0.0039
285 CEREBRAL INFARCTION 96 0.0039
286 FEMORAL NECK FRACTURE 20 0.0039
287 BLOOD CHOLESTEROL ABNORMAL 18 0.0039
288 SCOLIOSIS 24 0.0039
289 STAPHYLOCOCCAL SEPSIS 19 0.0038
290 EPIGASTRIC DISCOMFORT 15 0.0038
291 PULMONARY MASS 57 0.0038
292 MENINGITIS ASEPTIC 17 0.0038
293 JOINT DISLOCATION 40 0.0038
294 PRODUCT SUPPLY ISSUE 27 0.0038
295 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64 0.0038
296 MICTURITION URGENCY 43 0.0038
297 CHEST DISCOMFORT 384 0.0037
298 LOW DENSITY LIPOPROTEIN INCREASED 29 0.0037
299 ANURIA 32 0.0037
300 WEIGHT LOSS POOR 19 0.0037
301 PERIPHERAL COLDNESS 51 0.0037
302 CHOLANGITIS 23 0.0037
303 VENTRICULAR FIBRILLATION 41 0.0037
304 DYSPNOEA EXERTIONAL 139 0.0037
305 SYNOVIAL CYST 17 0.0037
306 HYPOGAMMAGLOBULINAEMIA 24 0.0036
307 JAW DISORDER 20 0.0036
308 VENTRICULAR TACHYCARDIA 60 0.0036
309 APATHY 53 0.0036
310 LYMPHOCYTE COUNT DECREASED 64 0.0036
311 FOOT DEFORMITY 40 0.0036
312 BLOOD MAGNESIUM DECREASED 31 0.0036
313 C-REACTIVE PROTEIN ABNORMAL 23 0.0036
314 MENISCUS INJURY 22 0.0036
315 BLOOD POTASSIUM INCREASED 58 0.0036
316 METABOLIC ACIDOSIS 114 0.0036
317 MUSCULAR WEAKNESS 400 0.0035
318 ENDOCARDITIS 18 0.0035
319 HAEMATOCRIT DECREASED 69 0.0035
320 SINUSITIS 356 0.0035
321 PANCREATITIS ACUTE 78 0.0035
322 FAECALOMA 19 0.0035
323 FALL 1154 0.0035
324 INFLUENZA LIKE ILLNESS 285 0.0035
325 COUGH 966 0.0034
326 ELECTROLYTE IMBALANCE 40 0.0034
327 SHOCK HAEMORRHAGIC 28 0.0034
328 CHILLS 403 0.0034
329 SEPSIS 380 0.0034
330 DUODENAL ULCER 24 0.0034
331 GASTROINTESTINAL DISORDER 303 0.0034
332 BLOOD CALCIUM DECREASED 38 0.0034
333 RHABDOMYOLYSIS 140 0.0034
334 MYOCARDIAL ISCHAEMIA 38 0.0033
335 PERICARDIAL EFFUSION 77 0.0033
336 PETIT MAL EPILEPSY 17 0.0033
337 NEUROLOGICAL SYMPTOM 19 0.0033
338 BLOOD CREATININE INCREASED 217 0.0033
339 URINARY RETENTION 110 0.0033
340 IMMUNE THROMBOCYTOPENIA 15 0.0033
341 ASTHMA 370 0.0033
342 ORAL CANDIDIASIS 43 0.0033
343 RENAL TUBULAR NECROSIS 32 0.0033
344 RENAL IMPAIRMENT 274 0.0033
345 HYPOPHOSPHATAEMIA 24 0.0032
346 MELAENA 71 0.0032
347 PSORIASIS 420 0.0032
348 HEPATIC ENCEPHALOPATHY 30 0.0032
349 INFLUENZA 358 0.0032
350 PROTEINURIA 61 0.0032
351 SINUS BRADYCARDIA 31 0.0032
352 HYDRONEPHROSIS 24 0.0032
353 WOUND 89 0.0032
354 SKIN EXFOLIATION 268 0.0032
355 ANAL FISSURE 17 0.0032
356 COLITIS MICROSCOPIC 15 0.0032
357 HEPATITIS 81 0.0032
358 ASPARTATE AMINOTRANSFERASE INCREASED 168 0.0032
359 IRON DEFICIENCY ANAEMIA 29 0.0031
360 HEPATIC ENZYME INCREASED 214 0.0031
361 MYALGIA 533 0.0031
362 DYSPHAGIA 297 0.0031
363 PRODUCTIVE COUGH 149 0.0031
364 ANAL INCONTINENCE 28 0.0031
365 HEART RATE DECREASED 109 0.0031
366 BLOOD PRESSURE DECREASED 206 0.0031
367 PALPITATIONS 363 0.0031
368 BLOOD CREATINE PHOSPHOKINASE INCREASED 89 0.0031
369 TACHYPNOEA 42 0.0031
370 CONFUSIONAL STATE 499 0.0031
371 MUSCULOSKELETAL STIFFNESS 270 0.0031
372 PERIPHERAL SENSORY NEUROPATHY 18 0.0031
373 HAEMORRHOIDAL HAEMORRHAGE 15 0.0031
374 BRADYPHRENIA 20 0.0031
375 BURSITIS 37 0.0030
376 ALANINE AMINOTRANSFERASE INCREASED 187 0.0030
377 NASOPHARYNGITIS 561 0.0030
378 RASH PAPULAR 68 0.0030
379 NERVE COMPRESSION 28 0.0030
380 LARGE INTESTINE POLYP 21 0.0030
381 INCONTINENCE 32 0.0030
382 NEURALGIA 73 0.0030
383 ORAL DISORDER 22 0.0030
384 HYPOTENSION 602 0.0030
385 CHOLECYSTITIS ACUTE 17 0.0030
386 SHOCK 69 0.0030
387 POOR VENOUS ACCESS 31 0.0030
388 CARDIAC FAILURE 240 0.0030
389 INFUSION RELATED REACTION 198 0.0030
390 PERICARDITIS 50 0.0030
391 RED BLOOD CELL COUNT DECREASED 85 0.0030
392 THERAPEUTIC PRODUCT EFFECT DECREASED 133 0.0030
393 FAECES DISCOLOURED 64 0.0029
394 POLYURIA 24 0.0029
395 TYPE 2 DIABETES MELLITUS 98 0.0029
396 INFLAMMATION 150 0.0029
397 ARTHROPATHY 161 0.0029
398 HEPATIC FUNCTION ABNORMAL 108 0.0029
399 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 205 0.0029
400 DIABETES MELLITUS INADEQUATE CONTROL 51 0.0029
401 EOSINOPHIL COUNT INCREASED 24 0.0029
402 TOXIC SKIN ERUPTION 29 0.0029
403 CIRCULATORY COLLAPSE 49 0.0029
404 NECROSIS 16 0.0029
405 WHEEZING 170 0.0029
406 ATRIAL FIBRILLATION 279 0.0029
407 PERIPHERAL SWELLING 440 0.0029
408 JOINT SWELLING 344 0.0028
409 ATRIOVENTRICULAR BLOCK 22 0.0028
410 ARRHYTHMIA 134 0.0028
411 ABDOMINAL PAIN 658 0.0028
412 ATELECTASIS 27 0.0028
413 PNEUMOCYSTIS JIROVECII PNEUMONIA 28 0.0028
414 EYE HAEMORRHAGE 37 0.0028
415 HYPERGLYCAEMIA 101 0.0028
416 ENTEROCOLITIS 16 0.0028
417 PYELONEPHRITIS 24 0.0028
418 ANGINA UNSTABLE 18 0.0028
419 ENCEPHALOPATHY 68 0.0028
420 SKIN WARM 16 0.0027
421 HAND DEFORMITY 36 0.0027
422 EXOSTOSIS 25 0.0027
423 INTERSTITIAL LUNG DISEASE 132 0.0027
424 DECREASED APPETITE 629 0.0027
425 APHTHOUS ULCER 21 0.0027
426 ASTHENIA 1018 0.0027
427 DEPRESSED LEVEL OF CONSCIOUSNESS 107 0.0027
428 HEART RATE IRREGULAR 61 0.0027
429 POOR QUALITY SLEEP 58 0.0027
430 HYPOTHYROIDISM 86 0.0027
431 HEART RATE ABNORMAL 15 0.0027
432 SLEEP DISORDER 189 0.0027
433 APPENDICITIS 25 0.0027
434 MOBILITY DECREASED 192 0.0027
435 DIVERTICULITIS 74 0.0027
436 SKIN LACERATION 29 0.0027
437 OEDEMA PERIPHERAL 325 0.0027
438 VITAMIN D DEFICIENCY 26 0.0027
439 HAEMOGLOBIN DECREASED 273 0.0027
440 PERIORBITAL SWELLING 15 0.0027
441 LIMB DISCOMFORT 82 0.0026
442 BLOOD ALBUMIN DECREASED 21 0.0026
443 BLOOD TEST ABNORMAL 37 0.0026
444 EAR DISCOMFORT 27 0.0026
445 COVID-19 PNEUMONIA 31 0.0026
446 MIDDLE INSOMNIA 49 0.0026
447 BLOOD CHOLESTEROL INCREASED 122 0.0026
448 HIP ARTHROPLASTY 40 0.0026
449 CORONARY ARTERY DISEASE 79 0.0026
450 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
451 PSORIATIC ARTHROPATHY 105 0.0026
452 BLINDNESS TRANSIENT 19 0.0026
453 EOSINOPHILIA 45 0.0026
454 DEAFNESS 67 0.0026
455 PEMPHIGUS 32 0.0026
456 ARTHRALGIA 1063 0.0026
457 MYOPATHY 22 0.0025
458 PULMONARY TOXICITY 18 0.0025
459 SEASONAL ALLERGY 36 0.0025
460 GAIT INABILITY 85 0.0025
461 BLADDER DISORDER 25 0.0025
462 PNEUMONIA 812 0.0025
463 PULMONARY CONGESTION 33 0.0025
464 GLOSSODYNIA 56 0.0025
465 ENDOPHTHALMITIS 15 0.0025
466 CARPAL TUNNEL SYNDROME 35 0.0025
467 BLOOD SODIUM DECREASED 47 0.0025
468 THYROID DISORDER 38 0.0025
469 HEAD INJURY 78 0.0025
470 RASH PRURITIC 133 0.0025
471 MYOSITIS 22 0.0024
472 LARGE INTESTINE PERFORATION 17 0.0024
473 HYPOALBUMINAEMIA 19 0.0024
474 MULTIPLE ORGAN DYSFUNCTION SYNDROME 69 0.0024
475 OSTEOPOROSIS 100 0.0024
476 WRIST FRACTURE 29 0.0024
477 BONE DISORDER 44 0.0024
478 FEELING COLD 67 0.0024
479 FREQUENT BOWEL MOVEMENTS 65 0.0024
480 SKIN LESION 66 0.0024
481 RASH ERYTHEMATOUS 115 0.0024
482 VISION BLURRED 330 0.0024
483 BLOOD THYROID STIMULATING HORMONE INCREASED 22 0.0024
484 ADRENAL INSUFFICIENCY 29 0.0024
485 TUMOUR LYSIS SYNDROME 21 0.0024
486 ATRIAL FLUTTER 19 0.0024
487 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
488 COGNITIVE DISORDER 111 0.0024
489 COLITIS ISCHAEMIC 16 0.0024
490 HAEMATOMA 61 0.0024
491 BODY TEMPERATURE INCREASED 48 0.0024
492 GENERAL PHYSICAL HEALTH DETERIORATION 271 0.0023
493 OBSTRUCTIVE AIRWAYS DISORDER 26 0.0023
494 METASTASES TO LUNG 27 0.0023
495 POST PROCEDURAL INFECTION 19 0.0023
496 NEPHROTIC SYNDROME 16 0.0023
497 KNEE ARTHROPLASTY 49 0.0023
498 FRACTURE 44 0.0023
499 RESTLESSNESS 85 0.0023
500 LIVER INJURY 57 0.0023
501 LOCALISED INFECTION 56 0.0023
502 GASTRIC ULCER 44 0.0023
503 LYMPHOEDEMA 16 0.0023
504 FACE OEDEMA 39 0.0023
505 THERAPEUTIC RESPONSE DECREASED 140 0.0023
506 SUBDURAL HAEMATOMA 33 0.0023
507 PYREXIA 796 0.0023
508 LOWER RESPIRATORY TRACT INFECTION 104 0.0023
509 LIVER FUNCTION TEST INCREASED 49 0.0023
510 DYSURIA 84 0.0023
511 MALAISE 1000 0.0023
512 SMALL INTESTINAL OBSTRUCTION 28 0.0023
513 DISSEMINATED INTRAVASCULAR COAGULATION 32 0.0023
514 BLOOD POTASSIUM DECREASED 68 0.0023
515 PURPURA 20 0.0023
516 INTENTIONAL PRODUCT USE ISSUE 198 0.0023
517 ERECTILE DYSFUNCTION 58 0.0023
518 PHARYNGITIS 28 0.0023
519 DISSOCIATION 17 0.0022
520 PHARYNGITIS STREPTOCOCCAL 24 0.0022
521 VENTRICULAR EXTRASYSTOLES 23 0.0022
522 HYPERTHYROIDISM 32 0.0022
523 FEBRILE NEUTROPENIA 146 0.0022
524 LIVER FUNCTION TEST ABNORMAL 64 0.0022
525 UPPER GASTROINTESTINAL HAEMORRHAGE 37 0.0022
526 METASTASES TO BONE 36 0.0022
527 ANGIOEDEMA 97 0.0022
528 ASPIRATION 24 0.0022
529 HYPOPHAGIA 56 0.0022
530 PULMONARY OEDEMA 98 0.0022
531 SOMNOLENCE 440 0.0022
532 PRODUCT ADMINISTRATION ERROR 44 0.0022
533 MUSCLE RIGIDITY 26 0.0022
534 ACUTE CORONARY SYNDROME 18 0.0022
535 ELECTROCARDIOGRAM QT PROLONGED 78 0.0022
536 ELECTROCARDIOGRAM ABNORMAL 17 0.0022
537 GAMMA-GLUTAMYLTRANSFERASE INCREASED 48 0.0022
538 COAGULOPATHY 36 0.0022
539 DEHYDRATION 287 0.0021
540 UPPER RESPIRATORY TRACT INFECTION 99 0.0021
541 BRONCHITIS 158 0.0021
542 HEPATIC CIRRHOSIS 40 0.0021
543 MIGRAINE 203 0.0021
544 URINARY INCONTINENCE 63 0.0021
545 ARTERIOSCLEROSIS 20 0.0021
546 INSOMNIA 566 0.0021
547 TOOTH INFECTION 28 0.0021
548 VOMITING 998 0.0021
549 VERTIGO 129 0.0021
550 OROPHARYNGEAL DISCOMFORT 19 0.0021
551 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 54 0.0021
552 DISCOMFORT 128 0.0021
553 DYSPNOEA 1186 0.0021
554 TREATMENT FAILURE 173 0.0021
555 END STAGE RENAL DISEASE 38 0.0021
556 BLOOD LACTATE DEHYDROGENASE INCREASED 33 0.0021
557 DERMATITIS BULLOUS 15 0.0021
558 CLOSTRIDIUM DIFFICILE INFECTION 45 0.0021
559 PALLOR 56 0.0021
560 PANCYTOPENIA 115 0.0021
561 DIZZINESS 1026 0.0021
562 GENERALISED TONIC-CLONIC SEIZURE 34 0.0021
563 GROIN PAIN 18 0.0020
564 SARS-COV-2 TEST POSITIVE 27 0.0020
565 HEPATOMEGALY 20 0.0020
566 FLANK PAIN 19 0.0020
567 SCAB 23 0.0020
568 ABDOMINAL PAIN UPPER 415 0.0020
569 JOINT INJURY 43 0.0020
570 DRY MOUTH 163 0.0020
571 HEART RATE INCREASED 198 0.0020
572 PHOTOSENSITIVITY REACTION 33 0.0020
573 HYPOKINESIA 29 0.0020
574 SECRETION DISCHARGE 25 0.0020
575 ANAEMIA 380 0.0020
576 UVEITIS 27 0.0020
577 PLEURAL EFFUSION 121 0.0020
578 AORTIC ANEURYSM 15 0.0020
579 HEADACHE 1234 0.0020
580 ACIDOSIS 15 0.0020
581 PNEUMONIA ASPIRATION 49 0.0020
582 ISCHAEMIC STROKE 35 0.0020
583 PROSTATIC SPECIFIC ANTIGEN INCREASED 27 0.0020
584 CEREBRAL HAEMORRHAGE 70 0.0020
585 CEREBROVASCULAR ACCIDENT 331 0.0020
586 RIB FRACTURE 40 0.0019
587 JOINT STIFFNESS 51 0.0019
588 RENAL FAILURE 258 0.0019
589 CONTUSION 187 0.0019
590 BLOOD CALCIUM INCREASED 17 0.0019
591 MYELODYSPLASTIC SYNDROME 28 0.0019
592 HAEMOPTYSIS 54 0.0019
593 ERYTHEMA MULTIFORME 18 0.0019
594 DIARRHOEA 1245 0.0019
595 GASTROOESOPHAGEAL REFLUX DISEASE 155 0.0019
596 OROPHARYNGEAL PAIN 178 0.0019
597 FATIGUE 1497 0.0019
598 CHOLELITHIASIS 63 0.0019
599 GASTROENTERITIS 28 0.0019
600 LIVER DISORDER 85 0.0019
601 RESPIRATORY RATE INCREASED 17 0.0019
602 TORSADE DE POINTES 15 0.0019
603 BLISTER 107 0.0019
604 HEPATOCELLULAR INJURY 27 0.0019
605 BEDRIDDEN 25 0.0019
606 UNRESPONSIVE TO STIMULI 49 0.0019
607 DEMENTIA 53 0.0019
608 NERVE INJURY 21 0.0019
609 IMMUNODEFICIENCY 28 0.0019
610 CHOLESTASIS 36 0.0019
611 PRURITUS 720 0.0019
612 PULMONARY HYPERTENSION 39 0.0019
613 POLLAKIURIA 78 0.0019
614 BLOOD TRIGLYCERIDES INCREASED 33 0.0019
615 SUBARACHNOID HAEMORRHAGE 19 0.0019
616 TENDON RUPTURE 23 0.0019
617 GASTRITIS 49 0.0019
618 LETHARGY 107 0.0019
619 DIABETES MELLITUS 141 0.0018
620 PHARYNGEAL SWELLING 18 0.0018
621 SEDATION 48 0.0018
622 ABNORMAL FAECES 15 0.0018
623 EYE DISCHARGE 19 0.0018
624 HICCUPS 15 0.0018
625 ABDOMINAL PAIN LOWER 46 0.0018
626 MUSCLE ATROPHY 23 0.0018
627 TOXICITY TO VARIOUS AGENTS 305 0.0018
628 EAR INFECTION 48 0.0018
629 RASH MACULO-PAPULAR 40 0.0018
630 RESPIRATORY FAILURE 131 0.0018
631 DIABETIC KETOACIDOSIS 43 0.0018
632 INTERVERTEBRAL DISC PROTRUSION 39 0.0018
633 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17 0.0018
634 SEPTIC SHOCK 77 0.0018
635 BACTERIAL INFECTION 33 0.0018
636 FIBROMYALGIA 43 0.0018
637 PNEUMOTHORAX 28 0.0018
638 LUPUS-LIKE SYNDROME 16 0.0018
639 CHOLECYSTITIS 21 0.0018
640 BALANCE DISORDER 152 0.0018
641 HAEMATOCHEZIA 97 0.0018
642 OBESITY 28 0.0018
643 DIZZINESS POSTURAL 17 0.0018
644 NAUSEA 1384 0.0017
645 JAUNDICE 47 0.0017
646 PARKINSONISM 17 0.0017
647 BLOOD BILIRUBIN INCREASED 47 0.0017
648 HYPERBILIRUBINAEMIA 18 0.0017
649 INCREASED APPETITE 33 0.0017
650 ORAL DISCOMFORT 24 0.0017
651 FLUID OVERLOAD 25 0.0017
652 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 40 0.0017
653 CONSTIPATION 374 0.0017
654 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 309 0.0017
655 ANXIETY 486 0.0017
656 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 89 0.0017
657 HYPOXIA 60 0.0017
658 WHITE BLOOD CELL COUNT INCREASED 65 0.0017
659 SCIATICA 27 0.0017
660 BACTERAEMIA 20 0.0017
661 URINARY TRACT INFECTION 287 0.0017
662 SWELLING 157 0.0017
663 COVID-19 294 0.0017
664 CARDIOGENIC SHOCK 24 0.0017
665 IMMUNE SYSTEM DISORDER 22 0.0017
666 AGRANULOCYTOSIS 31 0.0017
667 CELLULITIS 84 0.0017
668 PULMONARY EMBOLISM 158 0.0017
669 DYSPEPSIA 163 0.0017
670 LOSS OF CONSCIOUSNESS 212 0.0017
671 SKIN DISCOLOURATION 76 0.0017
672 RESPIRATORY TRACT INFECTION 43 0.0016
673 NASAL CONGESTION 97 0.0016
674 HYPOAESTHESIA 247 0.0016
675 PRODUCT USE ISSUE 310 0.0016
676 HYPOACUSIS 71 0.0016
677 COLD SWEAT 29 0.0016
678 INTESTINAL OBSTRUCTION 62 0.0016
679 CONDITION AGGRAVATED 500 0.0016
680 HAEMORRHOIDS 32 0.0016
681 DISORIENTATION 65 0.0016
682 DISEASE RECURRENCE 78 0.0016
683 COLITIS 62 0.0016
684 FEEDING DISORDER 33 0.0016
685 DERMATITIS 34 0.0016
686 INTERNATIONAL NORMALISED RATIO INCREASED 46 0.0016
687 SCRATCH 17 0.0016
688 ORAL PAIN 36 0.0016
689 SYSTEMIC LUPUS ERYTHEMATOSUS 57 0.0016
690 RENAL PAIN 17 0.0016
691 CLOSTRIDIUM DIFFICILE COLITIS 17 0.0016
692 BACK PAIN 372 0.0016
693 ATAXIA 19 0.0016
694 SUICIDE ATTEMPT 97 0.0016
695 DYSPHONIA 93 0.0016
696 PULMONARY ARTERIAL HYPERTENSION 23 0.0016
697 DEEP VEIN THROMBOSIS 103 0.0016
698 PNEUMONITIS 43 0.0016
699 HEPATOTOXICITY 35 0.0016
700 MYOCARDITIS 18 0.0016
701 ABDOMINAL DISTENSION 163 0.0016
702 CHROMATURIA 35 0.0015
703 CHEST PAIN 286 0.0015
704 AUTOIMMUNE DISORDER 15 0.0015
705 ORAL HERPES 30 0.0015
706 STEVENS-JOHNSON SYNDROME 34 0.0015
707 TRANSAMINASES INCREASED 34 0.0015
708 BURNING SENSATION 107 0.0015
709 INJECTION SITE DISCOLOURATION 19 0.0015
710 SKIN INFECTION 17 0.0015
711 ADVERSE REACTION 20 0.0015
712 RENAL FAILURE ACUTE 64 0.0015
713 DEPRESSION 342 0.0015
714 WEIGHT INCREASED 335 0.0015
715 PAIN IN EXTREMITY 440 0.0015
716 MALIGNANT MELANOMA 20 0.0015
717 HEPATIC CYTOLYSIS 19 0.0015
718 MUSCULOSKELETAL CHEST PAIN 23 0.0015
719 ANKLE FRACTURE 23 0.0015
720 DECREASED ACTIVITY 16 0.0015
721 PAIN 910 0.0015
722 MEDICATION ERROR 82 0.0015
723 RESPIRATORY DISORDER 44 0.0015
724 SPEECH DISORDER 77 0.0015
725 THROMBOCYTOPENIA 163 0.0015
726 PLATELET COUNT INCREASED 19 0.0015
727 SPINAL PAIN 17 0.0014
728 WEIGHT DECREASED 405 0.0014
729 ERYTHEMA 297 0.0014
730 PANCREATITIS 76 0.0014
731 LIMB INJURY 39 0.0014
732 COLITIS ULCERATIVE 64 0.0014
733 PRODUCT SUBSTITUTION ISSUE 82 0.0014
734 METASTASES TO LIVER 25 0.0014
735 HYPERHIDROSIS 183 0.0014
736 INTENTIONAL OVERDOSE 91 0.0014
737 EPISTAXIS 106 0.0014
738 PRODUCT DOSE OMISSION IN ERROR 40 0.0014
739 OEDEMA 76 0.0014
740 LACRIMATION INCREASED 42 0.0014
741 MUSCLE SPASMS 255 0.0014
742 PRODUCT PHYSICAL ISSUE 28 0.0014
743 CORONARY ARTERY OCCLUSION 19 0.0014
744 BACK INJURY 15 0.0014
745 ABSCESS 22 0.0014
746 NECK PAIN 77 0.0014
747 NEUTROPHIL COUNT DECREASED 56 0.0014
748 NEPHROLITHIASIS 63 0.0014
749 FOOT FRACTURE 26 0.0014
750 ILEUS 17 0.0014
751 PRODUCT USE IN UNAPPROVED INDICATION 339 0.0014
752 GASTROINTESTINAL HAEMORRHAGE 114 0.0014
753 OFF LABEL USE 1186 0.0014
754 IRRITABLE BOWEL SYNDROME 29 0.0014
755 GAIT DISTURBANCE 258 0.0013
756 MALNUTRITION 15 0.0013
757 RESPIRATORY DISTRESS 37 0.0013
758 THROAT IRRITATION 60 0.0013
759 DYSSTASIA 39 0.0013
760 NEUROPATHY PERIPHERAL 127 0.0013
761 PARAESTHESIA 210 0.0013
762 NIGHT SWEATS 43 0.0013
763 ILLNESS 137 0.0013
764 MOUTH ULCERATION 28 0.0013
765 BLOOD ALKALINE PHOSPHATASE INCREASED 33 0.0013
766 EYE INFECTION 15 0.0013
767 LUNG DISORDER 65 0.0013
768 ROTATOR CUFF SYNDROME 17 0.0013
769 FLATULENCE 75 0.0013
770 THERAPY NON-RESPONDER 59 0.0013
771 PERITONITIS 27 0.0013
772 GASTRIC HAEMORRHAGE 15 0.0013
773 RECTAL HAEMORRHAGE 56 0.0013
774 MUSCLE TIGHTNESS 21 0.0013
775 LIP SWELLING 43 0.0013
776 ANKYLOSING SPONDYLITIS 17 0.0013
777 DRY EYE 64 0.0013
778 RENAL INJURY 38 0.0013
779 PLATELET COUNT DECREASED 136 0.0013
780 GASTROENTERITIS VIRAL 23 0.0013
781 INTENTIONAL DOSE OMISSION 36 0.0013
782 FEELING HOT 77 0.0013
783 CYTOKINE RELEASE SYNDROME 25 0.0012
784 CANDIDA INFECTION 21 0.0012
785 VISUAL ACUITY REDUCED 41 0.0012
786 VIRAL INFECTION 41 0.0012
787 RENAL DISORDER 57 0.0012
788 DELUSION 19 0.0012
789 KIDNEY INFECTION 24 0.0012
790 ECZEMA 64 0.0012
791 MUSCULOSKELETAL PAIN 64 0.0012
792 THERAPY PARTIAL RESPONDER 19 0.0012
793 SOPOR 16 0.0012
794 SKIN CANCER 26 0.0012
795 HYPERSENSITIVITY 224 0.0012
796 ANAPHYLACTIC SHOCK 31 0.0012
797 SPINAL FRACTURE 24 0.0012
798 RASH 522 0.0012
799 FEMUR FRACTURE 37 0.0012
800 INTENTIONAL PRODUCT MISUSE 104 0.0012
801 MOVEMENT DISORDER 38 0.0012
802 FLUID RETENTION 60 0.0012
803 EPILEPSY 36 0.0012
804 CARDIAC ARREST 97 0.0012
805 TREMOR 195 0.0012
806 IMPAIRED GASTRIC EMPTYING 16 0.0012
807 SCAR 20 0.0012
808 TENDONITIS 18 0.0012
809 OSTEOMYELITIS 21 0.0012
810 BLOOD URINE PRESENT 22 0.0012
811 HOT FLUSH 87 0.0012
812 ILL-DEFINED DISORDER 70 0.0012
813 ABDOMINAL DISCOMFORT 193 0.0011
814 ADVERSE EVENT 106 0.0011
815 NODULE 15 0.0011
816 DRUG EFFECT LESS THAN EXPECTED 17 0.0011
817 APHONIA 16 0.0011
818 POST PROCEDURAL COMPLICATION 22 0.0011
819 TREATMENT NONCOMPLIANCE 62 0.0011
820 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
821 OSTEONECROSIS 37 0.0011
822 AMNESIA 73 0.0011
823 SWELLING FACE 73 0.0011
824 HIP FRACTURE 36 0.0011
825 JOINT RANGE OF MOTION DECREASED 15 0.0011
826 WHITE BLOOD CELL COUNT DECREASED 121 0.0011
827 DRY SKIN 149 0.0011
828 FEAR 30 0.0011
829 STOMATITIS 67 0.0011
830 LUNG INFECTION 17 0.0011
831 ACUTE MYELOID LEUKAEMIA 17 0.0011
832 ERUCTATION 21 0.0011
833 MALIGNANT NEOPLASM PROGRESSION 111 0.0011
834 BONE MARROW FAILURE 22 0.0011
835 MASS 15 0.0011
836 VISUAL IMPAIRMENT 133 0.0011
837 NEOPLASM PROGRESSION 37 0.0011
838 LEUKOPENIA 53 0.0011
839 ALOPECIA 208 0.0011
840 ANAPHYLACTIC REACTION 58 0.0010
841 MEMORY IMPAIRMENT 144 0.0010
842 HERPES ZOSTER 60 0.0010
843 HALLUCINATION, VISUAL 22 0.0010
844 TRANSIENT ISCHAEMIC ATTACK 35 0.0010
845 TOOTH DISORDER 23 0.0010
846 THROMBOSIS 83 0.0010
847 FEELING ABNORMAL 247 0.0010
848 BRAIN FOG 16 0.0010
849 LYMPHADENOPATHY 36 0.0010
850 NERVOUSNESS 53 0.0010
851 MYOCARDIAL INFARCTION 176 0.0010
852 EYE IRRITATION 58 0.0010
853 COLON CANCER 15 0.0010
854 RASH MACULAR 35 0.0010
855 BLOOD GLUCOSE INCREASED 187 0.0010
856 BONE PAIN 58 0.0010
857 FUNGAL INFECTION 33 0.0010
858 RETCHING 21 0.0010
859 DEPRESSED MOOD 52 0.0010
860 CARDIAC FAILURE CONGESTIVE 79 0.0010
861 IMPAIRED WORK ABILITY 21 0.0010
862 INJECTION SITE RASH 30 0.0010
863 BLOOD GLUCOSE ABNORMAL 18 0.0010
864 INFECTION 141 0.0010
865 EYE DISORDER 32 0.0010
866 PRODUCT PRESCRIBING ERROR 23 0.0010
867 THERAPEUTIC RESPONSE SHORTENED 32 0.0010
868 PSYCHOMOTOR HYPERACTIVITY 16 0.0010
869 SWOLLEN TONGUE 30 0.0010
870 SKIN DISORDER 32 0.0010
871 DRUG INEFFECTIVE 1264 0.0010
872 BLOOD GLUCOSE DECREASED 46 0.0010
873 NEUTROPENIA 130 0.0010
874 THERAPY INTERRUPTED 68 0.0010
875 THIRST 17 0.0010
876 PLASMA CELL MYELOMA 37 0.0009
877 MULTIPLE SCLEROSIS 45 0.0009
878 ACUTE RESPIRATORY FAILURE 18 0.0009
879 EAR PAIN 18 0.0009
880 OVERDOSE 197 0.0009
881 UPPER LIMB FRACTURE 18 0.0009
882 ADVERSE DRUG REACTION 81 0.0009
883 URTICARIA 150 0.0009
884 NEEDLE ISSUE 26 0.0009
885 TASTE DISORDER 18 0.0009
886 ROAD TRAFFIC ACCIDENT 37 0.0009
887 TOOTHACHE 16 0.0009
888 RESTLESS LEGS SYNDROME 16 0.0009
889 PRURITUS GENERALISED 19 0.0009
890 PRODUCT DISPENSING ERROR 19 0.0009
891 HYPERSOMNIA 25 0.0009
892 SKIN FISSURES 17 0.0009
893 MENTAL STATUS CHANGES 24 0.0009
894 HEPATIC FAILURE 26 0.0009
895 THERAPY CESSATION 44 0.0009
896 IMPAIRED HEALING 28 0.0009
897 OSTEONECROSIS OF JAW 21 0.0008
898 SEIZURE 98 0.0008
899 OCULAR HYPERAEMIA 40 0.0008
900 MUCOSAL INFLAMMATION 22 0.0008
901 HERNIA 16 0.0008
902 PRESCRIBED OVERDOSE 16 0.0008
903 PANIC ATTACK 30 0.0008
904 DYSGEUSIA 61 0.0008
905 THROAT TIGHTNESS 22 0.0008
906 DRUG ABUSE 67 0.0008
907 DISTURBANCE IN ATTENTION 43 0.0008
908 FLUSHING 81 0.0008
909 HAEMORRHAGE 83 0.0008
910 LOWER LIMB FRACTURE 15 0.0008
911 ACCIDENTAL OVERDOSE 28 0.0008
912 PRODUCT DOSE OMISSION ISSUE 225 0.0008
913 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 155 0.0008
914 DYSKINESIA 31 0.0008
915 GASTRIC DISORDER 26 0.0008
916 PROCEDURAL PAIN 21 0.0008
917 INJURY 53 0.0008
918 DISEASE PROGRESSION 89 0.0008
919 CARDIOVASCULAR DISORDER 19 0.0007
920 STAPHYLOCOCCAL INFECTION 24 0.0007
921 RESPIRATORY ARREST 20 0.0007
922 CARDIAC DISORDER 67 0.0007
923 UNDERDOSE 52 0.0007
924 PAIN IN JAW 20 0.0007
925 LUNG NEOPLASM MALIGNANT 29 0.0007
926 MUSCLE TWITCHING 16 0.0007
927 HALLUCINATION 52 0.0007
928 INJECTION SITE MASS 25 0.0007
929 MENTAL DISORDER 29 0.0007
930 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0007
931 PRODUCT AVAILABILITY ISSUE 15 0.0007
932 RASH GENERALISED 17 0.0007
933 EXPOSURE VIA SKIN CONTACT 17 0.0007
934 INCORRECT DOSE ADMINISTERED 149 0.0007
935 EYE SWELLING 24 0.0006
936 INJECTION SITE PRURITUS 43 0.0006
937 AGITATION 47 0.0006
938 EXPOSURE DURING PREGNANCY 39 0.0006
939 MOOD ALTERED 17 0.0006
940 DRUG RESISTANCE 16 0.0006
941 AGEUSIA 15 0.0006
942 MOOD SWINGS 19 0.0006
943 INJECTION SITE ERYTHEMA 72 0.0006
944 NIGHTMARE 20 0.0006
945 FOETAL EXPOSURE DURING PREGNANCY 46 0.0006
946 EYE PRURITUS 19 0.0006
947 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 30 0.0005
948 LABORATORY TEST ABNORMAL 16 0.0005
949 NEOPLASM MALIGNANT 36 0.0005
950 IRRITABILITY 32 0.0005
951 PREMATURE BABY 16 0.0005
952 SURGERY 31 0.0005
953 INJECTION SITE SWELLING 40 0.0005
954 DRUG ADMINISTRATION ERROR 16 0.0005
955 INJECTION SITE HAEMORRHAGE 41 0.0005
956 EXTRA DOSE ADMINISTERED 20 0.0005
957 PRODUCT DOSE OMISSION 32 0.0005
958 PRODUCT STORAGE ERROR 42 0.0005
959 INJECTION SITE PAIN 144 0.0005
960 CRYING 17 0.0005
961 ACNE 35 0.0005
962 ANGER 15 0.0004
963 HOSPITALISATION 68 0.0004
964 AGGRESSION 22 0.0004
965 DEATH 373 0.0004
966 BREAST CANCER 40 0.0004
967 INJECTION SITE BRUISING 34 0.0004
968 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
969 DRUG EFFECT INCOMPLETE 15 0.0004
970 PRODUCT QUALITY ISSUE 52 0.0004
971 SUICIDAL IDEATION 35 0.0004
972 WITHDRAWAL SYNDROME 16 0.0004
973 DERMATITIS ATOPIC 20 0.0004
974 ACCIDENTAL EXPOSURE TO PRODUCT 37 0.0004
975 UNEVALUABLE EVENT 27 0.0004
976 DRUG WITHDRAWAL SYNDROME 30 0.0003
977 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 23 0.0003
978 PROSTATE CANCER 26 0.0003
979 EMOTIONAL DISTRESS 35 0.0003
980 CONVULSION 16 0.0003
981 SKIN BURNING SENSATION 20 0.0003
982 INJECTION SITE REACTION 19 0.0003
983 DEVICE ISSUE 22 0.0002
984 NO ADVERSE EVENT 43 0.0002
985 COMPLETED SUICIDE 19 0.0002
986 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
987 DRUG DOSE OMISSION 20 0.0001
988 DRUG DEPENDENCE 16 0.0001